Immune checkpoint inhibitor (ICI) associated corneal allograft rejection.

Marjon P, Echegoyen J, Schanzlin DJ, Gibbs PG, McClay EF

Open source

DOI
10.1016/j.ctarc.2026.101306
Published
2026
Container
Cancer treatment and research communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101306,
  title = {Immune checkpoint inhibitor (ICI) associated corneal allograft rejection.},
  author = {Marjon P and Echegoyen J and Schanzlin DJ and Gibbs PG and McClay EF},
  year = {2026},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2026.101306},
  url = {https://doi.org/10.1016/j.ctarc.2026.101306}
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitor (ICI) associated corneal allograft rejection.
AU  - Marjon P
AU  - Echegoyen J
AU  - Schanzlin DJ
AU  - Gibbs PG
AU  - McClay EF
PY  - 2026
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2026.101306
UR  - https://doi.org/10.1016/j.ctarc.2026.101306
ER  - 

APA

P, M., J, E., DJ, S., PG, G., & EF, M. (2026). Immune checkpoint inhibitor (ICI) associated corneal allograft rejection.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101306

Source records